Retinal Disease Composition with Synergistic Antioxidants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for complementary treatment methods and compositions for retinal diseases, particularly ischemic and degenerative retinal conditions, as existing treatments do not adequately address the protection and functional recovery of the retina.

Innovation Solution

A composition comprising astaxanthin, piperine, boswellic acids, coenzyme Q10, curcuminoids, lutein, saffron, zeaxanthin, and optional additional antioxidants like resveratrol, bromelain, zinc, and copper, which promotes retinal protection and functional recovery by inhibiting TNFa expression and enhancing retinal function in post-ischemic stress conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing treatments are used for retinal diseases, then standard care is provided, but protection and functional recovery of the retina are not adequately addressed

Engineering Contradiction:
Improveretinal protection and functional recoveryVSAvoidcomplementary treatment options
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple natural compounds (astaxanthin, piperine, boswellic acids, coenzyme Q10, curcuminoids, lutein, saffron, zeaxanthin, resveratrol, bromelain, zinc, salicin) into a single compositional formulation to achieve synergistic protective effects on the retina that individual compounds cannot provide alone

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite therapeutic formulation integrating antioxidants, anti-inflammatory agents, and neuroprotective compounds from natural sources, forming a multi-component system that addresses multiple pathological mechanisms of retinal disease simultaneously

Inventive Principle:
Principle #40Composite materials

2Reliability

If a single compound is used for treatment, then the treatment is simple, but the efficacy in promoting retinal functional recovery is insufficient

Engineering Contradiction:
Improvefunctional recovery efficacyVSAvoidcomposition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Multiple natural compounds with complementary mechanisms of action are merged into one formulation to achieve synergistic effects that enhance retinal protection and functional recovery beyond what any single compound can accomplish

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The compositional formulation serves multiple therapeutic functions simultaneously: antioxidant protection, anti-inflammatory action, neuroprotection, and metabolic support, making it a multi-functional treatment for retinal diseases

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP3634456B1Composition for use in treating retinal diseases
Publication Date: 2023.11.22 S I F I SPA
  • EP3634456B1 patent drawingFigure 1A~2

AI summary

The present invention relates to a composition comprising: astaxanthin, piperine, boswellic acids, coenzyme Q10, curcuminoids, lutein, zeaxanthin, saffron, copper and, optionally, resveratrol, bromelain, zinc, salicin and further antioxidants from natural sources. The present invention further relates to said composition for use in treating retinal diseases which are ischemic and/or degenerative in nature.